Isleworth Healthcare Acquisition Corp. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/12/2022 | Q2 2022 | $0.08 | $0 | |||
| 05/20/2022 | Q1 2022 | $0.41 | $0 | |||
| 03/29/2022 | Q4 2021 | $0.36 | $0 | |||
| 11/16/2021 | Q3 2021 | $0.94 | $0 | |||
| 08/24/2021 | Q2 2021 | -$1.16 | $0 | |||
| 06/07/2021 | Q1 2021 | $1.98 | $0 | |||
| 06/21/2016 | Q1 2016 | $0.61 | $264.87 M | |||
| 02/26/2016 | Q4 2015 | $0.17 | $230.54 M | |||
| 12/04/2015 | Q3 2015 | $0.19 | $236.26 M | |||
| 09/04/2015 | Q2 2015 | $0.21 | $246.92 M | |||
| 06/17/2015 | Q1 2015 | -$0.06 | $274.65 M | |||
| 02/27/2015 | Q4 2014 | $0.18 | $241.06 M | |||
| 12/04/2014 | Q3 2014 | -$0.03 | $238.92 M | |||
| 08/29/2014 | Q2 2014 | -$0.06 | $241.65 M | |||
| 06/23/2014 | Q1 2014 | -$4.18 | $260.78 M | |||
| 03/04/2014 | Q4 2013 | -$0.23 | $204.52 M | |||
| 12/05/2013 | Q3 2013 | $0.20 | $241.58 M | |||
| 09/06/2013 | Q2 2013 | -$0.12 | $247.73 M | |||
| 07/02/2013 | Q1 2013 | -$0.18 | $268.07 M | |||
| 02/20/2013 | Q4 2012 | -$0.04 | $238.10 M |
Isleworth Healthcare Acquisition Corp. Earnings: Frequently Asked Questions
-
How can I listen to Isleworth Healthcare Acquisition Corp.'s earnings conference call?
The conference call for Isleworth Healthcare Acquisition Corp.'s latest earnings report can be listened to online.
-
How can I read Isleworth Healthcare Acquisition Corp.'s conference call transcript?
The conference call transcript for Isleworth Healthcare Acquisition Corp.'s latest earnings report can be read online.
-
How much profit does Isleworth Healthcare Acquisition Corp. generate each year?
Isleworth Healthcare Acquisition Corp. (:ISLE) has a recorded net income of $0. Isleworth Healthcare Acquisition Corp. has generated $0.47 earnings per share over the last four quarters.
-
What is Isleworth Healthcare Acquisition Corp.'s price-to-earnings ratio?
Isleworth Healthcare Acquisition Corp. (:ISLE) has a price-to-earnings ratio of 21.4 and price/earnings-to-growth ratio is 0.21.
